September 15th, 2018
MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate
April 4th, 2018
NIH launches HEAL Initiative, doubles funding to accelerate scientific solutions to stem national opioid epidemic
December 5th, 2017
‘Biased’ opioids could yield safer pain relief
New compounds activate opioid receptor in a way that protects breathing
October 19th, 2017
Mebias’ mu opioids best morphine, Trevena drug in preclinical studies
October 16th, 2017
MEBIAS Discovery LLC Presents Pre-Clinical Data on Mu Opioid Receptor Pain Compounds at ADDC